TP53 and B-cell chronic lymphocytic leukemia: In CLL/SLL, TP53 aberrations, loss of CDKN2A gene, NOTCH1 mutations, unmutated immunoglobulin heavy chain variable region (IGHV) status, and stereotyped BCR subset 8 at diagnosis were reported to be associated with RT development [20–23].